# New Lp(a) lowering drug

**URL:** <https://www.rapamycin.news/t/new-lp-a-lowering-drug/10504>\
**Category:** General\
**Created:** [November 13, 2023, 7:50pm UTC](https://www.rapamycin.news/t/new-lp-a-lowering-drug/10504 "2023-11-13T19:50:26Z")\
**Posts on this page:** 1\
**Showing post:** 256

<div class="post-metadata">

**Author:** ![Nick1](https://www.rapamycin.news/user_avatar/www.rapamycin.news/nick1/32/32565_2.png) [@Nick1](https://www.rapamycin.news/u/Nick1)\
**Post date:** [September 5, 2026, 10:33pm UTC](https://www.rapamycin.news/t/new-lp-a-lowering-drug/10504/256 "2026-09-05T22:33:54Z")

</div>

> [@Lipoprotein a Phase 3 Trial results - Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal](https://www.rapamycin.news/t/lipoprotein-a-phase-3-trial-results/26462):
>
> Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal The Phase 3 study found a drug didn’t reduce the risk of cardiovascular events such as heart attacks and strokes [https://www.wsj.com/health/pharma/novartis-says-closely-watched-cholesterol-study-failed-to-meet-goal-7901cb11?mod=mhp](https://www.wsj.com/health/pharma/novartis-says-closely-watched-cholesterol-study-failed-to-meet-goal-7901cb11?mod=mhp)

---

_[View the full topic](https://www.rapamycin.news/t/new-lp-a-lowering-drug/10504)._